Skip to main content
FinSpry Logo
FinSpry
N
NGEN
(NASDAQ)
NervGen Pharma Corp.
$3.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NervGen Pharma (NGEN) Stock Price & Financial Analysis

NervGen Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.57 - $3.72
52-Week High$6.30
52-Week Low$1.50
Open$3.60
Volume137.72K
Average Volume (3M)200.37K
Market Cap263.28M
Shares Outstanding72.33M
Price to Book (P/B)101.97
EV/EBITDA-27.10
50-Day MA$3.95
200-Day MA$3.59
52-Week Change51.03%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NervGen Pharma

What is the current stock price for NGEN?

As of the latest trading session, NGEN stock trades at $3.64. The 52-week range is $1.50–$6.30, with a day range of $3.57–$3.72.

What is the P/E ratio for NGEN?

The P/E ratio (Price-to-Earnings) for NGEN is shown in the Key Statistics section. This valuation metric helps compare NervGen Pharma Corp. to industry peers.

Does NGEN pay dividends?

NervGen Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NGEN?

Based on 1 analyst, the consensus for NGEN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NGEN?

NervGen Pharma's market capitalization is $263.3M, classifying it as a micro-cap company. NervGen Pharma operates in the Healthcare sector within the Biotechnology industry.